Trial Profile
A study investigating the effect of adalimumab on extraintestinal manifestations in patients with Crohn's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 20 Nov 2015 New trial record